Anebulo Pharmaceuticals, Inc. (ANEB)

Anebulo Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is July - June.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021
Cash & Equivalents	9.04	11.63	3.09	11.25	14.55	19.99
Cash & Short-Term Investments	9.04	11.63	3.09	11.25	14.55	19.99
Cash Growth	-39.72%	275.80%	-72.49%	-22.69%	-27.21%	560.69%
Other Receivables	0.06	0.07	-	-	-	-
Receivables	0.06	0.07	-	-	-	-
Prepaid Expenses	0.18	0.26	0.41	0.42	1.03	1.67
Total Current Assets	9.27	11.96	3.51	11.67	15.58	21.65
Other Long-Term Assets	0.15	0.18	0.57	-	-	-
Total Assets	9.42	12.15	4.07	11.67	15.58	21.65
Accounts Payable	0.55	0.22	0.16	0.53	0.38	0.11
Accrued Expenses	0.93	0.26	0.1	0.53	0.13	0.13
Total Current Liabilities	1.49	0.49	0.26	1.07	0.51	0.24
Total Liabilities	1.49	0.49	0.26	1.07	0.51	0.24
Common Stock	0.04	0.04	0.03	0.03	0.02	0.02
Additional Paid-In Capital	85.94	85.51	69.19	67.78	60.51	60.03
Retained Earnings	-78.05	-73.89	-65.4	-57.2	-45.47	-38.64
Total Common Equity	7.94	11.66	3.81	10.6	15.07	21.41
Shareholders' Equity	7.94	11.66	3.81	10.6	15.07	21.41
Total Liabilities & Equity	9.42	12.15	4.07	11.67	15.58	21.65
Net Cash (Debt)	9.04	11.63	3.09	11.25	14.55	19.99
Net Cash Growth	-39.72%	275.80%	-72.49%	-22.69%	-27.21%	607.78%
Net Cash Per Share	0.22	0.34	0.12	0.45	0.62	1.47
Filing Date Shares Outstanding	40.78	41.08	25.93	25.63	23.37	23.34
Total Common Shares Outstanding	41.08	41.08	25.93	25.63	23.34	23.34
Working Capital	7.79	11.47	3.25	10.6	15.07	21.41
Book Value Per Share	0.19	0.28	0.15	0.41	0.65	0.92
Tangible Book Value	7.94	11.66	3.81	10.6	15.07	21.41
Tangible Book Value Per Share	0.19	0.28	0.15	0.41	0.65	0.92

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q